Mark Mellinger

2.1k citations
9 papers · 1.8k · 1 hit paper · h-index 8

Impact in

    • Epigenetics and DNA Methylation
    • Genomics and Chromatin Dynamics
    • Cancer-related gene regulation
    • Chromatin Remodeling and Cancer
    • Protein Degradation and Inhibitors
    • Lymphoma Diagnosis and Treatment

Papers in

    • Advanced Synthetic Organic Chemistry 5
    • Synthesis and Reactions of Organic Compounds 2
    • Synthesis and Reactivity of Sulfur-Containing Compounds 1
    • Synthesis and pharmacology of benzodiazepine derivatives 1
    • Synthesis and Biological Activity 2

Mark Mellinger

9 papers receiving 1.7k citations

Mark Mellinger's Hit Papers

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations 2012 · 1.5k citations
1.5k0+4+9Years since publication5001k1.5k

Peers

Mark Mellinger
Comparison fields: 5 of 65
  • Molecular Biology 1k
  • Pathology and Forensic Medicine 207
  • Cancer Research 116
  • Organic Chemistry 272
  • Oncology 159
Replace Céline Duquenne with:
Céline Duquenne United States
Josh Bliesath United States
Elsie Diaz United States
Normand Beaulieu Canada
Kevin Hudson United Kingdom
Christopher J. Sneeringer United States
Christina J. Allain United States
Kimberly N. Smitheman United States
Dineli Wickramasinghe United States
Matthias Hoffmann Germany
Mark Mellinger relative to Céline Duquenne United States Céline Duquenne's profile →
Citations per field
00.5×1.7×
Céline Duquenne · 1×
Citations per year

Countries citing papers authored by Mark Mellinger

Since Specialization
Citations

This map shows the geographic impact of Mark Mellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mellinger more than expected).

Fields of papers citing papers by Mark Mellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mellinger. The network helps show where Mark Mellinger may publish in the future.

Co-authors

The 10 scholars most cited alongside Mark Mellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Mellinger Line = papers co-authored together Mark Mellinger links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Hit paper breakdown →
20121507
2 2000145
3 199649
4 200228
5 199626
6 199625
7 199420
8 199513
9 20243

About Mark Mellinger

Mark Mellinger is a scholar working on Organic Chemistry, Cancer Research, Molecular Biology, Infectious Diseases and Nuclear Energy and Engineering, having authored 9 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Synthetic Organic Chemistry (5 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and Biological Activity (2 papers), Synthesis and Reactions of Organic Compounds (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Epigenetics and DNA Methylation (1 paper), Synthesis and Reactivity of Sulfur-Containing Compounds (1 paper) and Synthesis and pharmacology of benzodiazepine derivatives (1 paper). The work is most often cited by research in Molecular Biology (1k citations), Pathology and Forensic Medicine (207 citations), Cancer Research (116 citations), Organic Chemistry (272 citations) and Oncology (159 citations). Mark Mellinger has collaborated with scholars based in United States and Spain. Frequent co-authors include Joseph Sisko, Mark A. Olsen, Andrew C. Allen, Andrew J. Kassick, Joseph Fortunak, Peter W. Sheldrake, Neil H. Baine, Zhi‐Ping Zhuang, John Kitteringham and Patrick L. Burk. Their work appears in journals such as Tetrahedron Letters, The Journal of Organic Chemistry, Nature, Bioorganic & Medicinal Chemistry and Pure and Applied Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact